- Completed a total of 25 human application tests (including one clinical test combining ampoule and mist usage)
Potential Side Effects and Prevalence Like any medication, there is an inherent risk of adverse effects, and unfortunately, with this class of medications, they are quite common
For patients, this means: when an FDA shortage of the brand exists (semaglutide was in shortage 2022-2024
Compared with insulin, GLP-1 therapy often provides: Weight loss instead of weight gain Lower risk of hypoglycemia Fewer injections (weekly options) Better patient satisfaction However, insulin remains essential for many individuals, especially those with Type 1 diabetes, severe hyperglycemia, or advanced beta-cell failure
Many insurance plans cover Tirzepatide for reducing body fat purposes
Eligible people on Medicare will have a $50 co-pay